Merck pulls Vioxx from drug market and faces class actions suit

On September 30, 2004, the pharmaceutical company, Merck, pulled its arthritis drug, Vioxx from the worldwide market, due to strokes and heart attacks in patients, but the move did not stop over 45,000 former-users and their families from suing Merck. The plaintiffs, however, have struggled to collect damages awarded to them in successful litigations.

Learn more about the plaintiffs in these suits from the New York Times.
--------

advertisement

Support JURIST

We rely on our readers to keep JURIST running


 Donate now!
 

About This Day at Law

This Day at Law is JURIST's platform for legal history, highlighting interseting and important developments that shaped the law and the world.

© Copyright JURIST Legal News and Research Services, Inc., 2013.